Picture of Gilead Sciences logo

GILD Gilead Sciences Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareConservativeLarge CapSuper Stock

Annual balance sheet for Gilead Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments25,51030,08924,3527,4086,520
Net Total Accounts Receivable
Net Total Receivables3,8513,3273,5824,8924,493
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets31,82335,83630,29615,99614,772
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment3,2954,0065,1705,6135,663
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets70,28363,67561,62768,40767,952
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities11,63510,6059,75911,39711,610
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities49,84142,28839,10250,20546,883
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity20,44221,38722,52518,20221,069
Total Liabilities & Shareholders' Equity70,28363,67561,62768,40767,952
Total Common Shares Outstanding

Or unlock with your email

Or unlock with your email